The Trump administration said Tuesday evening it's sending out 100 cease-and-desist letters to drug companies as part of a crackdown on what it called misleading direct-to-consumer ads.
The big picture: Meanwhile, President Trump signed a memorandum directing Health and Human Services Secretary Robert F. Kennedy Jr. to enforce transparency on pharmaceutical advertising, including increasing the amount of information in the ads about risks of using the drugs.
